SATURDAY PRESENTATIONS · “A 22-year-old man died after completing his first London Marathon because he drank too much water. David Rogers collapsed at the end of the race and died

September 7-9, 2018Kiawah Island Golf Resort

Kiawah Island, SC

2018 Annual Meeting

Carolinas Chapter - American Association of Clinical Endocrinologists

SATURDAY PRESENTATIONS

This continuing medical education activity is jointly provided by the Carolinas Chapter-AACE and Southern Regional Health Education Center

recent advances in the evaluation and treatment

of hyponatremia

Joseph G. Verbalis, MDProfessor of Medicine and PhysiologyChief, Endocrinology and Metabolism

Director, Georgetown-Howard UniversitiesCenter for Clinical and Translational Science

Georgetown UniversityWashington, DC USA

1

Joseph G. Verbalis: disclosures

consultant: Cumberland, Ferring, Otsuka

advisory board: Corcept, Otsukadata safety board: Ferringgrant support: NIA, NCATS

2

hyponatremia: association with

adverse outcomes

3

relationship between hospital admission serum [Na+] and in-hospital mortality

Wald et al. Arch Intern Med 170:294-302, 2010

0.20

0.15

0.10

0.05

110 115 120 125 130 135 140 145Admission Serum [Na+] Concentration (mEq/L)

Pred

icte

d Pr

obab

ility

of

In-H

ospi

tal M

orta

lity

St. Elizabeth’s MC2000-2007n = 53,236

4

Holland-Bill et al. Eur J Endocrinol 173:71-81, 2015

hyponatremia on admission is associated with increased subsequent 30-day and 1-year mortality (279,508 acutely hospitalized patients in Denmark 2006-2011)

5

chronic hyponatremia is also associated with increased adverse outcomes

significantly increased risk of fracture

increased mortality over a 12-year period of outpatient follow-up

Hoorn et al. J Bone Mineral Res 26:1822-8, 20116

hyponatremia: brain adaptation to

hyponatremia

7

patients 14 52duration < 12 hrs 3 daysserum [Na+] 112 ± 2 118 ± 1 stupor or coma 100% 6%seizures 29% 4%mortality 50% 6%low [Na+] deaths 36% 0%

acute chronic

Arieff et al. Medicine 56:121, 1976 (hospital consults in one year; [Na+]<128 mmol/L)

acute hyponatremia is associated with high morbidity and mortality

8

normal brain hyponatremic brain

acute hyponatremia can cause death from cerebral edema and brain herniation

Gross, Kidney Int 60:2417-27, 20019

“A 22-year-old man died after completing his first London Marathon because he drank too much water. David Rogers collapsed at the end of the race and died yesterday in Charing Cross Hospital.”

“Today it emerged the fitness instructor from Milton Keynes died from hyponatraemia, or water intoxication. This is when there is so much water in the body that it dilutes vital minerals such as sodium down to dangerous levels. It can lead to confusion, headaches and a fatal swelling of the brain.”

p[Na+] = 122 mmol/Ldrank Lucozade http://www.dailymail.co.uk/news/article-

450341/Marathon-victim-died-drinking-MUCH-water.html

London marathon, April 22, 2007

10

Hew-Butler et al. Br J Sports Med 49:1432, 2015

recommendations:

• drink only to thirst, no forced hydrationortake USATF sweat test to gauge true fluid requirements

• decrease water/sport drink stops at endurance events• point of care electrolyte testing at medical tent

11

patients 14 52duration < 12 hrs 3 daysserum [Na+] 112 ± 2 118 ± 1 stupor or coma 100% 6%seizures 29% 4%mortality 50% 6%low [Na+] deaths 36% 0%

acute chronic

Arieff et al. Medicine 56:121, 1976 (hospital consults in one year; [Na+]<128 mmol/L)

chronic hyponatremia is associated with much less severe symptomatology

12

1. true loss of brain solute

2. can reduce or eliminate brain edema despite severe hypoosmolality

3. time dependent process

brain volume regulation

Gullans & Verbalis Ann Rev Med

44:289-301, 1993

13

brain electrolyte and osmolyte losses after 7d of sustained hyponatremia

nearly 1/3 of brain volume regulation occurs as a result of losses of organic osmolytes

Gullans & Verbalis, Annu Rev Med 44:289-301, 199314

1. true loss of brain solute

2. can reduce or eliminate brain edema despite severe hypoosmolality

3. time dependent process

brain volume regulation

THIS IS NOT A NORMAL BRAIN!Gullans & Verbalis

Ann Rev Med44:289-301, 1993

15

hyponatremia: brain deadaptation:

osmotic demyelinationsyndrome

16

central pontine myelinolysis:white areas in the middle of the pons indicate massive demyelination of descending axons (corticobulbarand corticospinaltracts)

Wright, Laureno & Victor Brain 102:361-385, 1979

17

osmotic demyelination syndrome: clinical manifestations

• tremor• incontinence• hyperreflexia, pathological

reflexes• quadriparesis, quadriplegia• dysarthria, dysphagia• cranial nerve palsies• mutism, locked-in syndrome

18

normonatremic rat hyponatremic rat, 24 hours after

rapid correction

C3d immunohistochemical staining

19

differentiating goals from limits of correction of hyponatremiare-lowering of serum [Na+] is only recommended in patients with high risk of ODS

Verbalis et al, Am J Med 126:S1-42, 2013

20


patients at high risk of ODS

21

lower [Na+] and BUN levels predict greater rates of correction of hyponatremia with tolvaptan

Morris et al, AJKD 71:772, 2018

n=28 patients with SIADH)

22

rapid correction of hyponatremia occurs frequently, but ODS occurs rarely

increase in [Na+] >8 mmol/L/24h: 606/1490 = 41%osmotic demyelination by MRI: 8/1490 = 0.5%

George et al, CJASN 13:984-92, 201823

Verbalis et al, Am J Med

126:S1-42, 2013

guidelines for managing excessive corrections of hyponatremia to decrease risk of ODS

24

hyponatremia: symptom-based treatment

recommendations

25

treatments for hyponatremia

isotonic saline infusionhypertonic saline infusionvaptan (conivaptan, tolvaptan)

fluid restrictiondemeclocyclinefurosemide + NaClmineralocorticoidsureavaptan (tolvaptan)

long-term

short-term

26

symptomatic hyponatremia:neurological manifestations

• headache• irritability• nausea / vomiting• mental slowing• unstable gait / falls• confusion / delerium • disorientation

• stupor / coma• convulsions• respiratory arrest

life-threatening; usually acute

symptomatic butless impaired;usually chronic

the degree of symptomatologyis a surrogate for the duration

of hyponatraemia

27

hyponatremia treatment algorithm based on neurological symptoms

ALL: hypertonic NaCl1, followed by fluid restriction ± vaptan2

LEVEL 3 – SEVERE SYMPTOMS:coma, obtundation, seizures,respiratory distress, vomiting

1 some authors recommend simultaneous treatment with desmopressin to limit speed of correction.2 no active therapy should be started within 24 hrs of hypertonic saline to decrease the chance of overly rapid correction of [Na+] and risk of ODS. 28

28

hypertonic saline correction• choose desired correction rate of plasma [Na+]

(e.g., 1.0 mEq/L/h)• obtain or estimate patient’s weight (e.g., 70 kg)• multiply weight X desired correction rate and

infuse as ml/h of 3% NaCl (e.g., 70 kg X 1.0 mEq/L/h = 70 ml/h infusion)

OR:• 100-200 ml bolus infusion (5-10 min) of 3% NaCl,

repeat every 30 min until goal reachedFOR ALL SALINE CORRECTIONS: • follow serum [Na+] and urine output every 2-4 hrs

during the active correction

29


HYPOVOLEMIC: solute repletion (isotonic NaCl iv or oral sodium replacement)3

EUVOLEMIC: vaptan, limited hypertonic NaCl, or urea, followed by fluid restrictionHYPERVOLEMIC: vaptan, followed by fluid restriction



LEVEL 2 – MODERATE SYMPTOMS: altered mental status,

disorientation, confusion, unexplained nausea, gait instability

1 some authors recommend simultaneous treatment with desmopressin to limit speed of correction.2 no active therapy should be started within 24 hrs of hypertonic saline to decrease the chance of overly rapid correction of [Na+] and risk of ODS.3 with isotonic NaCl infusion, serum [Na+] must be followed closely to prevent overly rapid correction and risk of ODS due to secondary water diuresis. 30

30

hyponatremia can be caused by dilution from retained water, or by depletionfrom electrolyte losses in excess of water

31

U-Na+ excretion for identification of EABV

Fenske W. et al, JCEM 92:2991- 2997, 2008

with diuretics without diuretics

32

Nielsen et al., JASN 10:647-663, 1999

X

33

diuresis:increased excretion of urine by the kidney; includes water and typically increased solute excretion as well

aquaresis:increased excretion of water by the kidney without increased solute, i.e., electrolyte-sparing excretion of free water by the kidney

34

tolvaptan: SALT studies andSALT-WATER open label extension study

Berl et al. J Am Soc Nephrol 4:705-712, 201035

012345678

*

**

Del

ta in

crea

se in

ser

umSo

dium

(mm

ol/L

) *P<.05

Control Tolvaptan

cirrhosis HF SIADH

SALT: mean increases in serum [Na+] after 30 d in patients with cirrhosis, HF, and SIADH

Schrier et al. NEJM 355:2099-2112, 2006

X36

osmotic demyelination syndrome (ODS)one case of CPM has been reported following correction of hyponatremia using a vaptan as monotherapy in >5,000 patients to date; two cases of ODS have been reported with combined use of tolvaptan and hypertonic (3%) NaCl

Wright, Laureno & Victor. Brain 102:361-385, 1979

37

7.4.3 Patients with SIAD

Spasovzki G et al. Nephrol Dial Transplant 29:Suppl 2:i1-i39, 2014 38

urea increases [Na+] via an osmotic diuresis

Sterns et al. Kidney Int 87:268-70, 2015

39

hyponatremia (HN) registry: initial therapies utilized in patients with a clinical diagnosis of SIADH

Greenberg et al. Kidney Int 88:167-77, 2015

salt tabs utilized in 8%

40

salt tablets can also increase [Na+] via an osmotic diuresis

urea: 30g = 500 mOsmols

NaCl tabs: 1g = 34 mOsmols

how many salt tablets does it take to equal the osmotic diuresis of 30g of urea?

500/34 = 15g of NaCl

41


HYPO: solute repletion (isotonic NaCl iv or oral sodium replacement)3

EU: vaptan, limited hypertonic NaCl, or urea, followed by fluid restrictionHYPER: vaptan, followed by fluid restriction


ALL: fluid restriction


LEVEL 2 – MODERATE SYMPTOMS: altered mental status,

disorientation, confusion, unexplained nausea, gait instability

LEVEL 1 – NO OR MINIMAL SYMPTOMS: difficulty concentrating, irritability, altered mood, depression,

unexplained headache

42

42

choice of appropriate initial therapy


Furst H et al. Am J Med Sci 319:240-244, 2000

urine/plasmaelectrolyte

ratio

recommendedfluid consumption

>1.0 0 mL

0.5–1.0 Up to 500 mL

<0.50 Up to 1 L

use of urine electrolytes to predict stringency of fluid restriction

44

success rates in treating hyponatremia by physicians in the HN Registry

diagnosis & treatment

Δ [Na+] ≥ 5 mmol/L

[Na+] ≥ 130 mmol/L

[Na+] ≥ 135 mmol/L

SIADH, no rx(n=168) 41% 45% 20%SIADH, FR (n=625) 44% 29% 10%SIADH, NS (n=384) 36% 20% 4%SIADH, tolvaptan (n=183) 78% 74% 40%SIADH, 3% NaCl (n=78) 60% 25% 13%

at discharge, serum [Na+] was <135 mmol/L in 75% of patients, and ≤130 mmol/L in 43% of patients

Verbalis et al. Am J Med 129(5):537.e9-537.e23, 2016 45

hyponatremia: effects of treatment

on outcomes

46

hyponatremia improvement is associated with reduced risk of mortality

Corona et al. PLOSone 10(4) Apr 23, 201547


update of hyponatremia treatment guidelines first published in 2007

48

49

Documents

SATURDAY PRESENTATIONS · “A 22-year-old man died after completing his first London Marathon because he drank too much water. David Rogers collapsed at the end of the race and died